Source: Alzheimer's research & therapy. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, IMAGEM POR RESSONÂNCIA MAGNÉTICA, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON (TENDÊNCIAS), DOENÇAS NEURODEGENERATIVAS
ABNT
SHA, Sharon J. et al. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's research & therapy, v. 7, p. 8, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13195-014-0093-y. Acesso em: 20 out. 2024.APA
Sha, S. J., Ghosh, P. M., Lee, S. E., Rastelli, C. C., Jagust, W., Kormak, J., et al. (2015). Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimer's research & therapy, 7, 8. doi:10.1186/s13195-014-0093-yNLM
Sha SJ, Ghosh PM, Lee SE, Rastelli CC, Jagust W, Kormak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Tempini MG, Kramer J, Boxer AL, Rabinovici GD. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography [Internet]. Alzheimer's research & therapy. 2015 ; 7 8.[citado 2024 out. 20 ] Available from: https://doi.org/10.1186/s13195-014-0093-yVancouver
Sha SJ, Ghosh PM, Lee SE, Rastelli CC, Jagust W, Kormak J, Rankin KP, Grinberg LT, Vinters HV, Mendez MF, Dickson DW, Seeley WW, Tempini MG, Kramer J, Boxer AL, Rabinovici GD. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography [Internet]. Alzheimer's research & therapy. 2015 ; 7 8.[citado 2024 out. 20 ] Available from: https://doi.org/10.1186/s13195-014-0093-y